Carmen B Rodriguez
Overview
Explore the profile of Carmen B Rodriguez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
147
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee Argov E, Rodriguez C, Agovino M, Schmitt K, Desperito E, Karr A, et al.
Cancer Causes Control
. 2024 Apr;
35(8):1133-1142.
PMID: 38607569
Purpose: Nationally legislated dense breast notification (DBN) informs women of their breast density (BD) and the impact of BD on breast cancer risk and detection, but consequences for screening participation...
2.
Alimena S, Stephenson B, Webber J, Wollborn L, Sussman C, Packard D, et al.
Cancer Prev Res (Phila)
. 2024 Feb;
17(4):177-185.
PMID: 38388186
Prevention Relevance: This study aimed to understand factors affecting miRNA expression, to ensure we create equitable screening tests for ovarian cancer that perform well in diverse populations. The goal is...
3.
Pichardo C, Chambers E, Sanchez-Johnsen L, Pichardo M, Gallo L, Talavera G, et al.
Soc Sci Med
. 2023 Sep;
336:116222.
PMID: 37776783
Background: Metabolic syndrome varies by socio-demographic characteristics, with younger (18-29 years) and older (50-69 years) Hispanic/Latino having higher prevalence compared to other groups. While there is substantial research on neighborhood...
4.
Acheampong T, Rodriguez C, ONeill S, Agovino M, Lee Argov E, Tehranifar P
Cancer Causes Control
. 2023 Apr;
34(7):611-619.
PMID: 37085746
Purpose: Personal aversion to scientific uncertainty may influence how women perceive the benefits of mammography, a breast cancer screening practice with conflicting scientific opinions and guidelines. Such associations may even...
5.
Acheampong T, Lee Argov E, Terry M, Rodriguez C, Agovino M, Wei Y, et al.
Cancer Causes Control
. 2022 Dec;
34(2):189.
PMID: 36565401
No abstract available.
6.
Lee Argov E, Rodriguez C, Agovino M, Wei Y, Shelton R, Kukafka R, et al.
Breast Cancer Res
. 2022 Dec;
24(1):95.
PMID: 36544225
Background: Dense breast notification (DBN) legislation aims to increase a woman's awareness of her personal breast density and the implications of having dense breasts for breast cancer detection and risk....
7.
Brotzman L, Shelton R, Austin J, Rodriguez C, Agovino M, Moise N, et al.
Cancer Med
. 2022 May;
11(20):3854-3862.
PMID: 35616300
Background: Professional guidelines in the U.S. do not recommend routine screening mammography for women ≥75 years with limited life expectancy and/or poor health. Yet, routine mammography remains widely used in...
8.
Acheampong T, Lee Argov E, Terry M, Rodriguez C, Agovino M, Wei Y, et al.
Cancer Causes Control
. 2022 Jan;
33(3):363-371.
PMID: 35022893
Purpose: The nonsteroidal anti-inflammatory drug aspirin is an agent of interest for breast cancer prevention. However, it is unclear if aspirin affects mammographic breast density (MBD), a marker of elevated...
9.
Austin J, Tehranifar P, Rodriguez C, Brotzman L, Agovino M, Ziazadeh D, et al.
Implement Sci Commun
. 2021 Sep;
2(1):110.
PMID: 34565481
Background: There is growing concern that routine mammography screening is overused among older women. Successful and equitable de-implementation of mammography will require a multi-level understanding of the factors contributing to...
10.
Austin J, Agovino M, Rodriguez C, Terry M, Shelton R, Wei Y, et al.
Cancer Epidemiol Biomarkers Prev
. 2021 Aug;
30(10):1913-1920.
PMID: 34348958
Background: New York State law mandates that women with dense breasts receive a written notification of their breast density (BD) and its implications, but data on the impact of dense...